Aeluma’s patented silicon-based photonics platform offers asymmetric AI-datacom upside, but the $11.60 stock remains a highly speculative bet on commercial qualification, funding, and eventual volume production.
Overview
Aeluma is an early-stage semiconductor and optoelectronics company attempting to transition from a U.S. government R&D contractor into a commercial supplier of AI datacom photodetectors, quantum-dot lasers, and heterogeneous-integration services. Its differentiated platform bonds compound-semiconductor layers to large-diameter silicon wafers, potentially lowering costs and providing up to 16 times the wafer area of conventional InP architectures. **The opportunity is large but the current business is not commercial:** more than 95% of FY2026 revenue came from government contracts, FY2026 revenue fell 4.3% to $4.515 million, and Q4 revenue of $582,000 missed $1.38 million consensus by approximately 57.8%. Profitability deteriorated sharply, with FY2026 gross profit down 43.0% to $2.059 million, operating loss of $10.185 million, and GAAP net loss of $9.159 million, or $(0.52) per diluted share. **The balance sheet provides meaningful optionality:** cash was $56.01 million with zero reported debt, supported by $20.1 million of Q4 ATM proceeds. Valuation at $11.60 implies a $223.48 million market capitalization, $167.47 million EV, and 50.1x trailing P/S. Near-term catalysts are the up-to-$30 million CHIPS Act award, installation and qualification of two G10 reactors, and binding tier-1 NRE contracts; failure to commercialize would make the premium valuation vulnerable.